CSFB launches $75m High Medical IPO

Premarketing got underway today (Wednesday) for the $75m IPO of Swiss medical devices manufacturer High Medical Technologies.

  • 09 Mar 2001
Email a colleague
Request a PDF
The company, which specialises in equipment for urology and orthopaedics departments, will list on the SWX New Market. Credit Suisse First Boston is sole bookrunner for the deal.

The company is planning to sell 390m shares in the base offering and 59m in the greenshoe. The total offering represents 53% of the company. The price range for the deal will be announced on March 26.

Of the issue, about half will be capital increase and half will be secondary. "The company is going to use the proceeds to finance internal growth, enter further collaboration arrangements and commission scientific and clinical surveys," said a banker close to the deal.

Bank Sarasin, Lombard Odier and Kantonalbank are co-managers.

  • 09 Mar 2001

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 Jan 2017
1 Citi 22,118.13 61 9.00%
2 Barclays 20,987.41 55 8.54%
3 JPMorgan 17,406.75 53 7.08%
4 HSBC 16,333.52 48 6.64%
5 Goldman Sachs 15,454.74 49 6.29%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 17 Jan 2017
1 Commerzbank Group 114.00 1 66.16%
2 CaixaBank 37.05 1 21.50%
3 UniCredit 10.62 1 6.17%
3 BNP Paribas 10.62 1 6.17%
Subtotal 172.30 3 100.00%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 17 Jan 2017
1 SG Corporate & Investment Banking 770.06 2 16.80%
2 Goldman Sachs 656.16 2 14.32%
3 JPMorgan 527.28 4 11.50%
4 Emirates NBD PJSC 408.38 1 8.91%
5 Deutsche Bank 321.53 3 7.01%